Affiliation: Food and Drug Administration
- Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007Wei Hua
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Rockville, MD 20852 1448, USA
Pediatr Infect Dis J 28:943-7. 2009..A review of RotaTeq (rotavirus vaccine live) clinical trial data revealed higher, though not statistically significantly, KD rates among RotaTeq vaccines than placebo recipients. In June 2007, the RotaTeq label was revised accordingly...